Cardiac and renal effects of sodium-glucose co-transporter 2 inhibitors in diabetes: JACC state-of-the-art review
Why MT-1 Never Went Mainstream (The Real Reason) It actually did get FDA approval but only as Afamelanotide (brand name Scenesse), an implant for a rare disorder called erythropoietic protoporphyria (EPP)
Additional savings on top of the lowest available cash price for GLP-1s: Patients can combine savings on their Body membership with access to the lowest cash prices for branded GLP-1s and additional saving options on Wegovy
Exercise Regularly: Engage in regular physical activity to promote overall health and improve liver function
Enhancement of impaired olfactory neural activation and cognitive capacity by Liraglutide, but not Dapagliflozin or Acarbose, in patients with type 2 diabetes: a 16-week randomized parallel comparative study
Regarding cerebrovascular outcomes, statin use significantly decreased the occurrence of major cerebrovascular events (OR 0.82, 95% CI 0.770.87) across all populations, with no statistically significant differences between individual agents